Literature DB >> 34153298

Esophageal Hypervigilance and Symptom-Specific Anxiety in Patients with Eosinophilic Esophagitis.

Tiffany H Taft1, Dustin A Carlson2, Madison Simons2, Sonia Zavala2, Ikuo Hirano2, Nirmala Gonsalves2, John E Pandolfino2.   

Abstract

BACKGROUND & AIMS: Patient symptom reporting often does not correlate with the pathophysiological markers of esophageal disease, including eosinophilic esophagitis (EoE). Esophageal hypervigilance and symptom-specific anxiety are emerging as important considerations in understanding symptom reporting. As such, we aimed to conduct the first study of these constructs in EoE.
METHODS: A retrospective review of an EoE patient registry was conducted and included eosinophils per high power field (from esophagogastroduodenoscopy biopsy: proximal, distal), endoscopic reference score, distal distensibility plateau (functional luminal imaging probe), Brief Esophageal Dysphagia Questionnaire, Visual Dysphagia Question of EoE Activity Index, Northwestern Esophageal Quality of Life scale, and the Esophageal Hypervigilance and Anxiety Scale. Correlational and regression analyses evaluated relationships of hypervigilance and anxiety with Brief Esophageal Dysphagia Questionnaire, Visual Dysphagia Question of EoE Activity Index, and Northwestern Esophageal Quality of Life scale when controlling for histology and endoscopic severity.
RESULTS: One hundred and three patients had complete data, 69.9% were male, and the mean (SD) age was 40.66 (13.85) years. Forty-one percent had elevated dysphagia and 46% had elevated hypervigilance and anxiety. Esophageal symptom-specific anxiety emerged as the most important predictor of Brief Esophageal Dysphagia Questionnaire severity (44.8% of the variance), Visual Dysphagia Question of EoE Activity Index severity (26%), and poor health-related quality of life (HRQoL) (55.3%). Hypervigilance was also important, but to a lesser extent. Pathophysiological variables did not significantly predict symptoms or HRQoL. Recent food impaction can predict symptom-specific anxiety and proton pump inhibitor use can reduce hypervigilance.
CONCLUSIONS: Hypervigilance and symptom-specific anxiety are important for our understanding of self-reported patient outcomes in EoE. These processes outweigh endoscopic and histologic markers of EoE disease activity across dysphagia, difficulty eating, and HRQoL. Clinicians should assess hypervigilance and anxiety, especially in patients with refractory symptoms and poor HRQoL.
Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Eosinophilic Esophagitis; Hypervigilance; Quality of Life; Symptom Severity; Symptom-Specific Anxiety

Mesh:

Year:  2021        PMID: 34153298      PMCID: PMC8463417          DOI: 10.1053/j.gastro.2021.06.023

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   33.883


  39 in total

1.  Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system.

Authors:  Ikuo Hirano; Nelson Moy; Michael G Heckman; Colleen S Thomas; Nirmala Gonsalves; Sami R Achem
Journal:  Gut       Date:  2012-05-22       Impact factor: 23.059

2.  Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease.

Authors:  T H Taft; J R Triggs; D A Carlson; L Guadagnoli; K N Tomasino; L Keefer; J E Pandolfino
Journal:  Aliment Pharmacol Ther       Date:  2018-03-12       Impact factor: 8.171

3.  The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life.

Authors:  T H Taft; E Kern; M A Kwiatek; I Hirano; N Gonsalves; L Keefer
Journal:  Aliment Pharmacol Ther       Date:  2011-08-02       Impact factor: 8.171

Review 4.  Eosinophilic esophagitis: latest insights from diagnosis to therapy.

Authors:  Alain Schoepfer; Carine Blanchard; Heather Dawson; Alfredo Lucendo; Aurelio Mauro; Camillo Ribi; Ekaterina Safroneeva; Edoardo V Savarino; Roberto Penagini
Journal:  Ann N Y Acad Sci       Date:  2018-05-15       Impact factor: 5.691

5.  Development of the Northwestern Esophageal Quality of Life Scale: A Hybrid Measure for Use Across Esophageal Conditions.

Authors:  Alyse Bedell; Tiffany H Taft; Laurie Keefer; John Pandolfino
Journal:  Am J Gastroenterol       Date:  2016-02-16       Impact factor: 10.864

6.  Assessing Adherence and Barriers to Long-Term Elimination Diet Therapy in Adults with Eosinophilic Esophagitis.

Authors:  Ryan Wang; Ikuo Hirano; Bethany Doerfler; Angelika Zalewski; Nirmala Gonsalves; Tiffany Taft
Journal:  Dig Dis Sci       Date:  2018-04-02       Impact factor: 3.199

7.  Validation in French of the Brief Esophageal Dysphagia Questionnaire in Patients Referred For Esophageal Manometry.

Authors:  Sabine Roman; Livia Anna Guadagnoli; Audrey Hastier; Estelle Becam; Meredith Ruth Ann Craven; John E Pandolfino; Marie Napoléon; Dustin A Carlson; Francois Mion; Tiffany Taft
Journal:  Dysphagia       Date:  2021-04-08       Impact factor: 3.438

8.  The Spanish version of the esophageal hypervigilance and anxiety score shows strong psychometric properties: Results of a large prospective multicenter study in Spain and Latin America.

Authors:  Daniel Cisternas; Tiffany Taft; Dustin A Carlson; Esteban Glasinovic; Hugo Monrroy; Paula Rey; Albis Hani; Andres Ardila-Hani; Ana Maria Leguizamo; Claudio Bilder; Andres Ditaranto; Amanda Varela; Joaquin Agotegaray; Jose Maria Remes-Troche; Antonio Ruiz de León; Julio Pérez de la Serna; Ingrid Marin; Jordi Serra
Journal:  Neurogastroenterol Motil       Date:  2021-02-13       Impact factor: 3.598

9.  AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis.

Authors:  Ikuo Hirano; Edmond S Chan; Matthew A Rank; Rajiv N Sharaf; Neil H Stollman; David R Stukus; Kenneth Wang; Matthew Greenhawt; Yngve T Falck-Ytter
Journal:  Gastroenterology       Date:  2020-05       Impact factor: 33.883

10.  Psychiatric Comorbidities and Psychiatric Medication Use Are Highly Prevalent in Patients With Eosinophilic Esophagitis and Associate With Clinical Presentation.

Authors:  Craig C Reed; S Ryanne Corder; Erin Kim; Emily Sanders; Manaswita Tappata; Swathi Eluri; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2020-06       Impact factor: 12.045

View more
  7 in total

Review 1.  Refractory eosinophilic esophagitis: what to do when the patient has not responded to proton pump inhibitors, steroids and diet.

Authors:  Alexandra L Strauss; Gary W Falk
Journal:  Curr Opin Gastroenterol       Date:  2022-07-01       Impact factor: 2.741

2.  General Well-being and Coping Strategies in Adult Eosinophilic Esophagitis Patients.

Authors:  Willemijn E de Rooij; Floor Bennebroek Evertsz; Aaltje Lei; Albert J Bredenoord
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725

Review 3.  Mechanisms and clinical management of eosinophilic oesophagitis: an overview.

Authors:  Luc Biedermann; Alex Straumann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-17       Impact factor: 73.082

Review 4.  Nutritional and Psychological Considerations for Dietary Therapy in Eosinophilic Esophagitis.

Authors:  Javier Molina-Infante
Journal:  Nutrients       Date:  2022-04-12       Impact factor: 6.706

5.  Psychological Stress Exacerbates Inflammation of the Ileum via the Corticotropin-Releasing Hormone-Mast Cell Axis in a Mouse Model of Eosinophilic Enteritis.

Authors:  Atsushi Kanamori; Fumio Tanaka; Masaki Ominami; Yuji Nadatani; Shusei Fukunaga; Koji Otani; Shuhei Hosomi; Noriko Kamata; Yasuaki Nagami; Koichi Taira; Yasuhiro Fujiwara
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

6.  Normal Values of High-resolution Anorectal Manometry of Healthy Indians.

Authors:  Rahul Deshmukh; Akash Shukla; Sanjay Chandnani; Pravin M Rathi; Pratik Tibdewal; Shubham Jain; Nitin Ramani; Parmeshwar Junare; Partha Debnath; Leela Shinde; Asif Bagwan; Megha Meshram
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725

Review 7.  Evidence-based treatments for eosinophilic esophagitis: insights for the clinician.

Authors:  Sara Feo-Ortega; Alfredo J Lucendo
Journal:  Therap Adv Gastroenterol       Date:  2022-01-19       Impact factor: 4.409

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.